Atlas Trials

The Impact of a Combination of Bifidobacterium Longum 35624® and 1714™ Strains in Adults With Irritable Bowel Syndrome

Clinical trial NCT04422327 · COMPLETED

Trial details

NCT number
NCT04422327
Sponsor
PrecisionBiotics Group Ltd.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
IBS - Irritable Bowel SyndromeDepression, Anxiety
Start date
2017-09-20
Primary completion
2018-02-12
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.